U.S. FDA nod for Natco Pharma’s generic of Novartis drug
Hyderabad-based company Natco Pharma’s shares closed less than 1% lower at ₹1,165.15 on the BSE on January 30, 2025. File Natco Pharma has received U.S. Food and Drug Administration (U.S. FDA) approval for Everolimus tablets for oral suspension, 2mg, 3mg and 5mg, a generic version of Novartis Pharmaceutical Corporation’s Afinitor Disperz. Marketing partner for…
Read More “U.S. FDA nod for Natco Pharma’s generic of Novartis drug ” »